Seagen Appoints David Epstein As New CEO

RTTNews | hace 985
Seagen Appoints David Epstein As New CEO

(RTTNews) - Biotechnology company Seagen Inc. (SGEN) announced Thursday that its Board of Directors has appointed David Epstein as Chief Executive Officer (CEO) and a member of the Board of Directors.

Epstein brings more than 30 years of experience in the biopharmaceutical industry, including more than 25 years at Novartis where he built its oncology business unit from initiation to second largest in the world.

He then served as CEO of Novartis Pharmaceuticals, a division of Novartis AG, from 2010 to mid-2016. More recently, he was executive partner at Flagship Pioneering.

In addition, Seagen announced that Roger Dansey, M.D., who has served as Seagen's Chief Medical Officer (CMO) since 2018 and as Interim CEO since May 2022, has been appointed President, Research and Development.

In this new role, Dansey will continue to serve as CMO reporting to Epstein.

read more
Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Inc. (PFE) announced Thursday the successful completion of its acquisition of biotechnology company Seagen Inc. (SGEN). Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion.
RTTNews | hace 586
U.S. Dollar Falls On Tariff Uncertainty

U.S. Dollar Falls On Tariff Uncertainty

The U.S. dollar fell against its major counterparts in the New York session on Tuesday, amid fading hopes of a trade deal between the country and Europe.
RTTNews | hace 14 minutos
Swiss Market Ends Lower Again

Swiss Market Ends Lower Again

The Switzerland market ended on a weak note on Tuesday, in line with market across Europe, as uncertainty over U.S. - EU trade talks and a lack of positive data rendered the mood cautious.
RTTNews | hace 3h 33min
European Stocks Close Weak On Trade Deal Concerns, Weak Earnings Updates

European Stocks Close Weak On Trade Deal Concerns, Weak Earnings Updates

European stocks closed weak on Tuesday, extending previous session's losses, amid growing uncertainty over U.S.- EU trade talks, and some disappointing earnings updates. Investors were largely cautious, assessing the possible move of the U.S. and the European Union in the event of the ongoing trade negotiations failing to result in any meaningful solution to the tariff issues.
RTTNews | hace 4h 9min
Bay Street Likely To Open On Weak Note

Bay Street Likely To Open On Weak Note

Canadian shares are likely to open lower on Tuesday, tracking weak European markets amid growing uncertainty over U.S. - EU trade talks. Weak crude oil and bullion prices may hurt as well. The economic calendar is blank and there are no big earnings news as well. The mood in the market is likely to remain cautious.
RTTNews | hace 8h 21min